Soros Fund Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Hold |
0
| – | – | – | 188 |
|
2018
Q4 | – | Sell |
-160,000
| Closed | -$3.45M | – | 195 |
|
2018
Q3 | $3.45M | Hold |
160,000
| – | – | 0.08% | 135 |
|
2018
Q2 | $3.89M | Buy |
+160,000
| New | +$3.89M | 0.06% | 157 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 263 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 260 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 254 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 287 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 323 |
|
2015
Q3 | – | Sell |
-423,308
| Closed | -$25M | – | 266 |
|
2015
Q2 | $25M | Buy |
+423,308
| New | +$25M | 0.23% | 95 |
|
2015
Q1 | – | Sell |
-4,859,966
| Closed | -$279M | – | 242 |
|
2014
Q4 | $279M | Sell |
4,859,966
-1,371,756
| -22% | -$78.9M | 3.05% | 3 |
|
2014
Q3 | $335M | Sell |
6,231,722
-1,041,518
| -14% | -$56M | 2.5% | 3 |
|
2014
Q2 | $381M | Sell |
7,273,240
-3,036,801
| -29% | -$159M | 2.87% | 2 |
|
2014
Q1 | $545M | Buy |
10,310,041
+994,041
| +11% | +$52.5M | 5.38% | 1 |
|
2013
Q4 | $373M | Buy |
9,316,000
+5,708,000
| +158% | +$229M | 3.17% | 1 |
|
2013
Q3 | $136M | Buy |
+3,608,000
| New | +$136M | 1.49% | 17 |
|